We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$6.59B
AUM Growth
-$836M
Cap. Flow
-$1.17B
Cap. Flow %
-17.84%
Top 10 Hldgs %
15.06%
Holding
1,801
New
509
Increased
232
Reduced
294
Closed
676

Sector Composition

Rank Sector Weight
1 Healthcare 2.73%
2 Communication Services 2.58%
3 Financials 2.16%
4 Technology 1.6%
5 Consumer Discretionary 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FITB
551
CALL
Fifth Third Bancorp
FITB
$52.4B
$1.86M 0.03%
50,000
-50,000
-50% -$1.74M
XIFR
552
XPLR Infrastructure LP
XIFR
$1.11B
$1.86M 0.03%
61,752
+56,752
+1,135% +$1.62M
BLFS icon
553
CALL
BioLife Solutions
BLFS
$1.59B
$1.85M 0.03%
99,900
-100
-0.1% -$1.75K
AUGX
554
CALL
DELISTED
Augmedix, Inc. Common Stock
AUGX
$1.84M 0.03%
450,800
+800
+0.2% +$3.58K
BRKR icon
555
CALL
Bruker
BRKR
$7.66B
$1.84M 0.03%
+19,600
New +$1.58M
PRGO icon
556
Perrigo
PRGO
$1.49B
$1.83M 0.03%
+57,000
New +$1.8M
SILK
557
CALL
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.83M 0.03%
+100,000
New +$1.59M
IRWD icon
558
PUT
Ironwood Pharmaceuticals
IRWD
$709M
$1.83M 0.03%
210,000
+150,000
+250% +$1.82M
PETQ
559
PUT
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$1.83M 0.03%
+100,000
New +$1.78M
CHRW icon
560
C.H. Robinson
CHRW
$18.1B
$1.83M 0.03%
+24,000
New +$1.88M
APLS
561
DELISTED
Apellis Pharmaceuticals
APLS
$1.82M 0.03%
31,000
-362,031
-92% -$23.1M
ZIM icon
562
PUT
ZIM Integrated Shipping Services
ZIM
$3.29B
$1.82M 0.03%
180,000
-40,000
-18% -$486K
GEHC icon
563
CALL
GE HealthCare
GEHC
$31.7B
$1.82M 0.03%
+20,000
New +$1.66M
FMX icon
564
CALL
Fomento Económico Mexicano
FMX
$43B
$1.81M 0.03%
+13,900
New +$1.82M
MPLX icon
565
MPLX
MPLX
$61.4B
$1.81M 0.03%
+43,500
New +$1.69M
CBRL icon
566
Cracker Barrel
CBRL
$1.28B
$1.81M 0.03%
24,838
+15,838
+176% +$1.15M
PACB icon
567
CALL
Pacific Biosciences
PACB
$447M
$1.8M 0.03%
479,700
-642,300
-57% -$3.76M
IMXI icon
568
PUT
International Money Express
IMXI
$370M
$1.79M 0.03%
78,600
+33,600
+75% +$705K
ARCB icon
569
PUT
ArcBest
ARCB
$3.23B
$1.78M 0.03%
+12,500
New +$1.64M
ALIT icon
570
CALL
Alight
ALIT
$453M
$1.77M 0.03%
9,000
+5,000
+125% +$905K
GL icon
571
Globe Life
GL
$14.3B
$1.77M 0.03%
+15,235
New +$1.86M
BFH icon
572
CALL
Bread Financial
BFH
$4.54B
$1.77M 0.03%
+47,400
New +$1.68M
QCOM icon
573
Qualcomm
QCOM
$171B
$1.76M 0.03%
+10,400
New +$1.61M
VRDN icon
574
PUT
Viridian Therapeutics
VRDN
$2.3B
$1.75M 0.03%
+100,000
New +$1.94M
MDLZ icon
575
Mondelez International
MDLZ
$79.2B
$1.75M 0.03%
25,000
-25,000
-50% -$1.82M

Similar funds

Caption Management's Q1 2024 Portfolio in Review

As of Q1 2024, Caption Management held 1,801 positions worth $6.59B, down 11% from $7.42B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Caption Management withdrew a net $1.17B in Q1 2024, closing 676 positions and reducing 294 holdings. Its most notable exit was Palo Alto Networks, an estimated $20.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, up from 2.7% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Caption Management opened a new position in Adobe worth $11.5M.

  • Caption Management's largest Q1 2024 buy was Adobe: 22,800 shares worth $11.5M.
  • Caption Management added most to Sarepta Therapeutics in Q1 2024, an estimated $18.4M increase.
  • Caption Management's biggest Q1 2024 reduction was Apellis Pharmaceuticals, cutting an estimated $23.1M.
  • Caption Management fully exited Palo Alto Networks in Q1 2024, selling an estimated $20.9M.
  • Caption Management's ten largest holdings make up 15% of its $6.59B portfolio in Q1 2024.
  • Caption Management opened 509 new positions and closed 676 in Q1 2024.
  • Caption Management's portfolio value fell 11% quarter-over-quarter to $6.59B.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.